Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Hikma Pharmaceuticals Share News (HIK)
HIK Share
Price
HIK Share
News
HIK Share
Chat
HIK Share
Trades1,041
HIK
Live RNS1
HIK Share
Charts
HIK Level 2
Console
HIK Live
Share Price
HIK Broker
Ratings
HIK Directors
Deals
HIK Financial
Diary
HIK
Fundamentals
HIK Short
Positions2
HIK
Media
HIK Company
Research
HIK Company
Timeline3
Hikma Pharmaceuticals Information
Share Price Information for Hikma Pharmaceuticals (HIK)
Share Price is delayed by 15 minutes
Get Live Data
1,524.00
4.00 (0.26%)
Bid:
1,518.00
Ask:
1,520.00
Spread:
2.00 (0.132%)
Market Cap:
£3.21b
Last checked at -
Last checked at 
Intraday Hikma Pharmaceuticals Share Chart
Hikma Pharmaceuticals News
22 May 2020
UK WINNERS & LOSERS SUMMARY: easyJet Lower Ahead Of Board Ouster Bid
UK WINNERS & LOSERS SUMMARY: easyJet Lower Ahead Of Board Ouster Bid
22 May 2020
Hikma Gets US FDA Approval For Generic Version Of Heart Drug Vascepa
Hikma Gets US FDA Approval For Generic Version Of Heart Drug Vascepa
22 May 2020
LONDON MARKET OPEN: Stocks Open Down; easyJet Set For Stelios Showdown
LONDON MARKET OPEN: Stocks Open Down; easyJet Set For Stelios Showdown
22 May 2020
Hikma gets FDA approval for generic version of 'Vascepa'
(Sharecast News) - Hikma Pharmaceuticals announced on Friday that its wholly-owned US subsidiary has received approval from the US Food and Drug Admin...
4 May 2020
UPDATE 2-FTSE 100 ends lower on U.S.-China tensions
* FTSE 100 down 0.2%, FTSE 250 drops 1.2%* Rolls Royce slumps on reports of job cuts* Health care, energy stocks gain* Largest UK firms expect 20% hit...
30 Apr 2020
UK WINNERS & LOSERS SUMMARY: Reckitt Rises After Bumper First Quarter
UK WINNERS & LOSERS SUMMARY: Reckitt Rises After Bumper First Quarter
30 Apr 2020
TOP NEWS: Hikma Pharmaceuticals Starts Strong; On Course For Guidance
TOP NEWS: Hikma Pharmaceuticals Starts Strong; On Course For Guidance
Follow the stocks
